End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.17 USD | +7.26% | +7.26% | -4.61% |
Evolution of the average Target Price on Sagimet Biosciences Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sagimet Biosciences Inc.
Goldman Sachs | |
HC Wainwright | |
Leerink Partners | |
JMP Securities | |
TD Cowen | |
Piper Sandler |
EPS Revisions
- Stock Market
- Equities
- SGMT Stock
- Consensus Sagimet Biosciences Inc.